Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse
Completed · Phase 2
Conditions studied: Brain and Central Nervous System Tumors
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of leflunomide in treating patients who have anaplastic astrocytoma in first relapse.
Key facts
- Study ID
- NCT00003775
- Run by
- Pfizer
- People needed
- 60
- Starts
- 1998-12-01
- Expected to finish
- 2006-05-01
- Last updated by the study team
- 2012-09-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- University of Colorado Cancer Center — Denver, Colorado, United States
- Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- University of Iowa College of Medicine — Iowa City, Iowa, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
- Henry Ford Hospital — Detroit, Michigan, United States
- Cancer Center of Albany Medical Center — Albany, New York, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- New York Neurological Institute — New York, New York, United States
- Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
- Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
- Barrett Cancer Center, The University Hospital — Cincinnati, Ohio, United States
- Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States
- Western Pennsylvania Cancer Institute — Pittsburgh, Pennsylvania, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- Simmons Cancer Center - Dallas — Dallas, Texas, United States
- University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- Cross Cancer Institute — Edmonton, Alberta, Canada
- British Columbia Cancer Agency — Vancouver, British Columbia, Canada
- Cancer Care Ontario-London Regional Cancer Centre — London, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.